Iver A. Langmoen
Blindern, 0317, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.
Journal: Cancers
Published: November 07, 2023
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.
Journal: Translational oncology
Published: May 30, 2022
Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy.
Journal: Neuro-oncology advances
Published: November 03, 2021
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
Journal: Neuro-oncology advances
Published: March 05, 2021
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.
Journal: Cancers
Published: May 31, 2020
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.
Journal: Clinical and translational medicine
Published: November 03, 2019
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Journal: Journal of cancer research and clinical oncology
Published: December 25, 2018
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
Journal: BMC cancer
Published: December 03, 2018
Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells.
Journal: Translational oncology
Published: June 16, 2018
The effect of ICP monitoring in severe traumatic brain injury: a propensity score-weighted and adjusted regression approach.
Journal: Journal of neurosurgery
Published: January 31, 2018
Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region.
Journal: Neoplasia (New York, N.Y.)
Published: December 10, 2017
Minimally Invasive Microsurgical Resection of Primary, Intradural Spinal Tumors is Feasible and Safe: A Consecutive Series of 83 Patients.
Journal: Neurosurgery
Published: April 17, 2016
Last Updated: 09/26/2026